Table 2.
Relationship among ERCC1 genotypes, mRNA expression and clinical characteristics of gastric cancer
| Clinical characteristics | n |
ERCC1 polymorphism |
χ2 | P |
ERCC1 mRNA |
χ2 | P | ||
| C/C (n = 45) | C/T + T/T (n = 44) | High value (n = 31) | Low value (n = 31) | ||||||
| Age (yr) | |||||||||
| ≥ 58 | 48 | 25 | 23 | 0.096 | 0.833 | 18 | 18 | 0 | 1.000 |
| < 58 | 41 | 20 | 21 | 13 | 13 | ||||
| Gender | |||||||||
| Male | 66 | 31 | 35 | 1.318 | 0.334 | 20 | 24 | 0.253 | 0.402 |
| Female | 23 | 14 | 9 | 11 | 7 | ||||
| TNM stage | |||||||||
| I-II | 19 | 13 | 6 | 3.082 | 0.079 | 6 | 6 | 0 | 1.000 |
| III-IV | 70 | 31 | 39 | 25 | 25 | ||||
| Grading | |||||||||
| G2 | 45 | 20 | 24 | 0.552 | 0.527 | 15 | 19 | 1.042 | 0.444 |
| G3 | 44 | 21 | 20 | 16 | 12 | ||||